DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
TEW-7197
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TEW-7197
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SRL-172
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
SRL-172
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETILEVODOPA
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Dopamine D3 receptor agonist
ETILEVODOPA
×
Maximum Phase:
2
First Approval:
None
UNII:
895X917GYE
Molecule Type:
Small molecule
Molecular Formula:
C11H15NO4
Molecular Weight:
225.24
AlogP:
0.53
PSA:
92.78
HBD:
3.0
HBA:
#RotB:
4.0
Source:
RONTALIZUMAB
2
Antibody
Investigational
Unknown
Unknown
Lupus Erythematosus, Systemic
Interferon alpha inhibitor
RONTALIZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
LDO2FIQ61I
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SIMTUZUMAB
2
Antibody
Investigational
Unknown
Unknown
Neoplasms; Cholangitis, Sclerosing; Colorectal Neoplasms; Idiopathic Pulmonary Fibrosis; Liver Cirrhosis; Pancreatic Neoplasms; Primary Myelofibrosis
Lysyl oxidase homolog 2 inhibitor
SIMTUZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
11Z5AIU653
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AFQ056
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AFQ056
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OBEXELIMAB
2
Antibody
Investigational
Unknown
Unknown
Lupus Erythematosus, Systemic
B-lymphocyte antigen CD19 inhibitor
OBEXELIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
RM16A4BA8R
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VESTIPITANT
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder; Depressive Disorder, Major; Phobia, Social; Postoperative Nausea and Vomiting; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Tinnitus
Unknown
VESTIPITANT
×
Maximum Phase:
2
First Approval:
None
UNII:
S052TOI9BI
Molecule Type:
Small molecule
Molecular Formula:
C23H24F7N3O
Molecular Weight:
491.45
AlogP:
5.93
PSA:
35.58
HBD:
1.0
HBA:
#RotB:
3.0
Source:
ODIPARCIL
2
Small molecule
Investigational
Unknown
Unknown
Atrial Fibrillation; Mucopolysaccharidosis VI
Glycosaminoglycans modulator
ODIPARCIL
×
Maximum Phase:
2
First Approval:
None
UNII:
FIK1414ZI8
Molecule Type:
Small molecule
Molecular Formula:
C15H16O6S
Molecular Weight:
324.35
AlogP:
0.64
PSA:
100.13
HBD:
3.0
HBA:
#RotB:
2.0
Source:
TELATINIB
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Stomach Neoplasms
Platelet-derived growth factor receptor beta inhibitor
TELATINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
18P7197Q7J
Molecule Type:
Small molecule
Molecular Formula:
C20H16ClN5O3
Molecular Weight:
409.83
AlogP:
3.95
PSA:
102.17
HBD:
2.0
HBA:
#RotB:
6.0
Source:
TALIZUMAB
2
Antibody
Investigational
Unknown
Unknown
Unknown
Ig epsilon chain C region inhibitor
TALIZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
9591BL735Z
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IDEC-159
2
Antibody
Investigational
Unknown
Unknown
Colorectal Neoplasms
Tumor-associated antigen 72 inhibitor
IDEC-159
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CNV2197944
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Neuropathies; Neuralgia, Postherpetic
Voltage-gated N-type calcium channel alpha-1B subunit blocker
CNV2197944
×
Maximum Phase:
2
First Approval:
None
UNII:
SSB9S6N20R
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALOVUDINE
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
ALOVUDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
PG53R0DWDQ
Molecule Type:
Small molecule
Molecular Formula:
C10H13FN2O4
Molecular Weight:
244.22
AlogP:
-0.54
PSA:
84.32
HBD:
2.0
HBA:
#RotB:
2.0
Source:
DAVUNETIDE
2
Protein
Investigational
Unknown
Unknown
Cognitive Dysfunction; Schizophrenia; Supranuclear Palsy, Progressive
Tubulin stabiliser
DAVUNETIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
GF00K3IIWE
Molecule Type:
Protein
Molecular Formula:
C36H60N10O12
Molecular Weight:
824.93
AlogP:
-4.34
PSA:
355.85
HBD:
10.0
HBA:
#RotB:
22.0
Source:
M1095
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
M1095
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
2-HYDROXYOLEIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Glioma; Glioblastoma
Unknown
2-HYDROXYOLEIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
OSV3KVO1BT
Molecule Type:
Small molecule
Molecular Formula:
C18H34O3
Molecular Weight:
298.47
AlogP:
5.08
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
15.0
Source:
MERICITABINE
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Hepatitis C, Chronic
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
MERICITABINE
×
Maximum Phase:
2
First Approval:
None
UNII:
TA63JX8X52
Molecule Type:
Small molecule
Molecular Formula:
C18H26FN3O6
Molecular Weight:
399.42
AlogP:
1.22
PSA:
122.74
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CEMDISIRAN
2
Oligonucleotide
Investigational
Unknown
Unknown
Atypical Hemolytic Uremic Syndrome; Glomerulonephritis, IGA; Hemoglobinuria, Paroxysmal
Complement C5 mRNA RNAi inhibitor
CEMDISIRAN
×
Maximum Phase:
2
First Approval:
None
UNII:
S66Z65E10T
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LB-100
2
Small molecule
Investigational
Unknown
Unknown
Myelodysplastic Syndromes; Neoplasms; Small Cell Lung Carcinoma; Glioblastoma; Oligodendroglioma
Serine/threonine protein phosphatase 2A, catalytic subunit, alpha isoform inhibitor
LB-100
×
Maximum Phase:
2
First Approval:
None
UNII:
0C1JUU9S0L
Molecule Type:
Small molecule
Molecular Formula:
C13H20N2O4
Molecular Weight:
268.31
AlogP:
-0.36
PSA:
70.08
HBD:
1.0
HBA:
#RotB:
2.0
Source:
SODIUM TUNGSTATE
2
Small molecule
Investigational
Unknown
Unknown
Obesity
Unknown
SODIUM TUNGSTATE
×
Maximum Phase:
2
First Approval:
None
UNII:
64LRH4405G
Molecule Type:
Small molecule
Molecular Formula:
Na2O4W
Molecular Weight:
293.82
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
INDIRUBIN
2
Small molecule
Investigational
Unknown
Unknown
Psoriasis
Unknown
INDIRUBIN
×
Maximum Phase:
2
First Approval:
None
UNII:
V86L8P74GI
Molecule Type:
Small molecule
Molecular Formula:
C16H10N2O2
Molecular Weight:
262.27
AlogP:
2.66
PSA:
58.2
HBD:
2.0
HBA:
#RotB:
0.0
Source:
SUVODIRSEN
2
Oligonucleotide
Investigational
Unknown
Unknown
Muscular Dystrophy, Duchenne
Dystrophin pre-mRNA positive modulator
SUVODIRSEN
×
Maximum Phase:
2
First Approval:
None
UNII:
IBX8A21EH6
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
METHYLSAMIDORPHAN
2
Small molecule
Investigational
Unknown
Unknown
Constipation
Mu opioid receptor antagonist
METHYLSAMIDORPHAN
×
Maximum Phase:
2
First Approval:
None
UNII:
8347HC35J6
Molecule Type:
Small molecule
Molecular Formula:
C22H29N2O4+
Molecular Weight:
385.48
AlogP:
1.4
PSA:
100.62
HBD:
3.0
HBA:
#RotB:
3.0
Source:
DIPHTHERIA TOXOID
2
Unknown
Investigational
Unknown
Unknown
Brain Neoplasms; Glioblastoma; Leukemia, Lymphocytic, Chronic, B-Cell; Meningitis; Meningococcal Infections; Severe Dengue
Unknown
DIPHTHERIA TOXOID
×
Maximum Phase:
2
First Approval:
None
UNII:
IRH51QN26H
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OLODANRIGAN
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Neuropathies; Neuralgia, Postherpetic
Angiotensin II type 2 (AT-2) receptor antagonist
OLODANRIGAN
×
Maximum Phase:
2
First Approval:
None
UNII:
P0FN522VTO
Molecule Type:
Small molecule
Molecular Formula:
C32H29NO5
Molecular Weight:
507.59
AlogP:
5.44
PSA:
76.07
HBD:
1.0
HBA:
#RotB:
8.0
Source:
SRX246
2
Small molecule
Investigational
Unknown
Unknown
Anxiety; Huntington Disease; Mood Disorders; Stress Disorders, Post-Traumatic
Vasopressin V1a receptor antagonist
SRX246
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C43H48F3N5O5
Molecular Weight:
771.88
AlogP:
6.6
PSA:
102.5
HBD:
1.0
HBA:
#RotB:
11.0
Source:
EPI-589
2
Unknown
Investigational
Unknown
Unknown
Amyotrophic Lateral Sclerosis; Parkinson Disease
Unknown
EPI-589
×
Maximum Phase:
2
First Approval:
None
UNII:
I4ZSB1Q2DU
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TETRAHYDROCANNABIVARIN
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
TETRAHYDROCANNABIVARIN
×
Maximum Phase:
2
First Approval:
None
UNII:
I5YE3I47D8
Molecule Type:
Small molecule
Molecular Formula:
C19H26O2
Molecular Weight:
286.42
AlogP:
4.96
PSA:
29.46
HBD:
1.0
HBA:
#RotB:
2.0
Source:
MB07811
2
Small molecule
Investigational
Unknown
Unknown
Hypercholesterolemia; Hyperlipidemias; Non-alcoholic Fatty Liver Disease
Thyroid hormone receptor beta-1 agonist
MB07811
×
Maximum Phase:
2
First Approval:
None
UNII:
3Z11398FNQ
Molecule Type:
Small molecule
Molecular Formula:
C28H32ClO5P
Molecular Weight:
514.99
AlogP:
8.08
PSA:
64.99
HBD:
1.0
HBA:
#RotB:
7.0
Source:
CANNABIDIOL ACID
2
Small molecule
Investigational
Unknown
Unknown
Hallux Valgus
Unknown
CANNABIDIOL ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
FJX8O3OJCD
Molecule Type:
Small molecule
Molecular Formula:
C22H30O4
Molecular Weight:
358.48
AlogP:
5.54
PSA:
77.76
HBD:
3.0
HBA:
#RotB:
7.0
Source:
DAROTROPIUM BROMIDE
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Muscarinic acetylcholine receptor antagonist
DAROTROPIUM BROMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
2W2V1U785A
Molecule Type:
Small molecule
Molecular Formula:
C24H29BrN2
Molecular Weight:
425.41
AlogP:
4.9
PSA:
23.79
HBD:
0.0
HBA:
#RotB:
4.0
Source:
EPALRESTAT
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Aldose reductase inhibitor
EPALRESTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
424DV0807X
Molecule Type:
Small molecule
Molecular Formula:
C15H13NO3S2
Molecular Weight:
319.41
AlogP:
2.92
PSA:
57.61
HBD:
1.0
HBA:
#RotB:
4.0
Source:
GUSPERIMUS
2
Small molecule
Investigational
Unknown
Unknown
Granulomatosis with Polyangiitis; Immune System Diseases
Unknown
GUSPERIMUS
×
Maximum Phase:
2
First Approval:
None
UNII:
UJ0ZJ76DO9
Molecule Type:
Small molecule
Molecular Formula:
C17H37N7O3
Molecular Weight:
387.53
AlogP:
-1.31
PSA:
178.38
HBD:
8.0
HBA:
#RotB:
17.0
Source:
FOLLICLE STIMULATING HORMONE (FSH)
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
FOLLICLE STIMULATING HORMONE (FSH)
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
171
172
173
174
175
176
177
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA